Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 9/20 | 0.75 |
| ▸ | FLT1 | P17948 | 4/20 | 0.74 |
| ▸ | FLT4 | P35916 | 4/20 | 0.74 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | NFATC1 | O95644 | 2/20 | 0.36 |
| ▸ | GSK3B | P49841 | 2/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | FLT3 | P36888 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7549926 | 0.89 | KDR (0.57) | KDRFLT1FLT4NFATC1GSK3B | |
| SCHEMBL7976012 | 0.89 | KDR (0.59) | KDRFLT1FLT4CYP2A6NFATC1 | |
| SCHEMBL7976915 | 0.89 | KDR (0.59) | KDRFLT1FLT4CYP2A6NFATC1 | |
| SCHEMBL7557708 | 0.87 | KDR (0.56) | KDRFLT1FLT4CYP2A6NFATC1 | |
| SCHEMBL7549555 | 0.87 | KDR (0.56) | KDRFLT1FLT4CYP2A6GSK3B | |
| SCHEMBL7994055 | 0.86 | KDR (0.56) | KDRFLT1FLT4CYP2A6 | |
| SCHEMBL7556531 | 0.86 | KDR (1.00) | KDRFLT1FLT4CYP2A6NFATC1 | |
| SCHEMBL7549908 | 0.86 | KDR (1.00) | KDRFLT1FLT4CYP2A6NFATC1 | |
| SCHEMBL7557245 | 0.85 | KDR (0.54) | KDRFLT1FLT4NFATC1GSK3B | |
| SCHEMBL7506453 | 0.85 | KDR (1.00) | KDRFLT1FLT4NFATC1GSK3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1147107-A4 | NOVEL ANGIOGENESIS INHIBITORS | MERCK & CO INC (US) | 2002-05-22 | — | — | EP | claimed |
| EP-1147107-A1 | NOVEL ANGIOGENESIS INHIBITORS | Merck & Co., Inc. (US) | 2001-10-24 | — | — | EP | claimed |
| WO-2000043393-A1 | NOVEL ANGIOGENESIS INHIBITORS | MERCK & CO., INC. (US) | 2000-07-27 | — | — | WO | claimed |
| EP-1147107-A4 | NOVEL ANGIOGENESIS INHIBITORS | MERCK & CO INC (US) | 2002-05-22 | — | — | EP | disclosed |
| EP-1147107-A1 | NOVEL ANGIOGENESIS INHIBITORS | Merck & Co., Inc. (US) | 2001-10-24 | — | — | EP | disclosed |
| US-6265403-B1 | TYROSINE INHIBITORS | MERCK & CO., INC. | 2001-07-24 | — | — | US | disclosed |
| WO-2000043393-A1 | NOVEL ANGIOGENESIS INHIBITORS | MERCK & CO., INC. (US) | 2000-07-27 | — | — | WO | disclosed |